Side Effects
GLP-1 and GERD: Managing Acid Reflux While on GLP-1 Medications
If you've recently started a GLP-1 medication and noticed that familiar burning sensation in your chest or a sour taste in your mouth, you're not alone. Many people experience acid reflux or worsening GERD symptoms when beginning GLP-1 therapy, and while it can be uncomfortable, it's usually manageable with the right approach.
The good news? Understanding the connection between GLP-1 medications and digestive symptoms can help you take steps to minimize discomfort while continuing to benefit from treatment.
Why GLP-1 Medications Can Trigger Acid Reflux
GLP-1 medications like semaglutide and tirzepatide work partly by slowing down how quickly your stomach empties. This delayed gastric emptying is actually one of the reasons these medications are so effective for weight loss, as it helps you feel fuller longer after meals.
However, when food stays in your stomach longer than usual, it can increase pressure in your stomach and make it easier for stomach acid to push back up into your esophagus. This is what causes that uncomfortable burning sensation known as heartburn or acid reflux.
For some people, this is a temporary adjustment as your body adapts to the medication. For others, especially those with a history of GERD, it may require ongoing management strategies.
Common GERD Symptoms to Watch For
While you're on GLP-1 therapy, it's helpful to recognize the signs that acid reflux might be becoming an issue:
- Burning sensation in your chest, especially after eating or when lying down
- Sour or bitter taste in your mouth
- Difficulty swallowing or feeling like food is stuck
- Chronic cough or throat clearing
- Hoarseness or changes in your voice
- Waking up at night with discomfort
If you're experiencing these symptoms regularly, don't just push through. There are effective ways to manage them.
Practical Strategies to Reduce Acid Reflux
Adjust Your Eating Habits
Since GLP-1 medications already slow digestion, how you eat becomes especially important. Smaller, more frequent meals put less pressure on your stomach than large meals. Aim to eat slowly and stop when you're comfortably satisfied rather than completely full.
Try to finish eating at least three hours before lying down. This gives your stomach time to empty somewhat before you're in a horizontal position where reflux is more likely to occur.
Be Strategic About Food Choices
Certain foods are more likely to trigger reflux, and this can be even more noticeable when you're on GLP-1 therapy. Common culprits include:
- Spicy or heavily seasoned foods
- Tomato-based sauces
- Citrus fruits and juices
- Chocolate
- Caffeine
- Alcohol
- Fried or high-fat foods
- Mint
You don't necessarily need to avoid all of these forever, but paying attention to which ones bother you personally can help you make informed choices.
Sleep Position Matters
Elevating the head of your bed by 6 to 8 inches can make a significant difference in nighttime reflux. This uses gravity to help keep stomach contents where they belong. You can use bed risers under the legs at the head of your bed, or try a wedge pillow designed for this purpose.
Simply stacking regular pillows usually doesn't work as well because it can cause you to bend at the waist, which actually increases abdominal pressure.
Consider Timing of Your Dose
Some people find that the timing of their GLP-1 injection affects their symptoms. While you should follow your prescribed schedule, if you're experiencing significant reflux, talk to your healthcare provider about whether adjusting the time of day you inject might help.
When to Talk to Your Doctor
While mild reflux can often be managed with lifestyle adjustments, certain symptoms warrant a conversation with your healthcare provider:
- Severe or persistent heartburn that doesn't improve with over-the-counter antacids
- Difficulty swallowing or painful swallowing
- Unintended weight loss beyond what's expected from your GLP-1 therapy
- Black or bloody stools
- Vomiting, especially if blood is present
- Symptoms that significantly interfere with your daily life or sleep
Your doctor may recommend prescription medications to reduce stomach acid, or in some cases, adjusting your GLP-1 dose or trying a different formulation.
Gender Considerations
Research suggests that women may be slightly more likely to experience gastrointestinal side effects from GLP-1 medications, including reflux symptoms. Hormonal fluctuations, particularly during perimenopause and menopause, can also affect digestive function and potentially compound reflux issues.
Men, on the other hand, may be less likely to report digestive discomfort even when experiencing it. If you're male and on GLP-1 therapy, don't dismiss mild symptoms, as addressing them early can prevent them from becoming more problematic.
The Bottom Line
Acid reflux and GERD symptoms are manageable side effects for most people on GLP-1 medications. With some thoughtful adjustments to your eating habits, sleep position, and food choices, you can often significantly reduce discomfort while continuing to benefit from treatment.
Remember that side effects often improve as your body adjusts to the medication, typically within the first few weeks to months. The key is not to suffer in silence. There are many effective strategies and treatments available to help you stay comfortable on your health journey.
From the Ozari Care Team
Start with the basics: eat smaller meals, avoid lying down within three hours of eating, and keep a simple food diary to identify your personal triggers. If symptoms persist beyond the first month or significantly impact your quality of life, reach out to your healthcare provider. Acid reflux doesn't have to derail your GLP-1 therapy when managed appropriately.
At Ozari Health we offer compounded Semaglutide and Tirzepatide starting at $99/month prescribed by licensed physicians and shipped to your door. Learn more at ozarihealth.com.
Medically reviewed by the Ozari Clinical Care Team, licensed physicians specializing in metabolic health and GLP-1 therapy. Last reviewed: April 25, 2026